Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4956-37-0
2. Oestradiol 17-heptanoate
3. Estradiol Enantate
4. Estradiol 17-heptanoate
5. Estradiol Enanthate [usan]
6. [(8r,9s,13s,14s,17s)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] Heptanoate
7. Sq 16,150
8. Pap315wzia
9. Sq-16150
10. So-16150
11. Sq-16,150
12. Estradiol Enanthate (usan)
13. Unii-pap315wzia
14. Ncgc00188442-01
15. Estradiol Heptanoate
16. Einecs 225-599-8
17. B-estradiol 17-enanthate
18. Dsstox_cid_3001
19. Dsstox_rid_76826
20. Beta-estradiol 17-enanthate
21. Dsstox_gsid_23001
22. Beta-estradiol 17-heptanoate
23. Mls006010232
24. Schembl547096
25. 17beta-estradiol 17-enanthate
26. Chembl1697792
27. Dtxsid3023001
28. Estra-1,3,5(10)-triene-3,17beta-diol 17-heptanoate
29. Chebi:135604
30. Estradiol Enantate [mart.]
31. Amy22313
32. Bcp28275
33. Estradiol Enantate [who-dd]
34. Hy-b1830
35. Zinc4215835
36. Tox21_113032
37. Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-heptanoate
38. Mfcd00056542
39. Akos015918000
40. Estradiol 17-heptanoate [mi]
41. Ds-2760
42. Smr004701310
43. Cas-4956-37-0
44. So 16,150
45. Cs-0013900
46. E1151
47. D04064
48. 956e370
49. A827747
50. Q5401763
51. Estra-1,3,5(10)-triene-3,17b-diol 17-heptanoate
52. N'-(imino(5-nitrofuran-2-yl)methyl)propionohydrazide
53. (17?)-3-hydroxyestra-1,3,5(10)-trien-17-yl Heptanoate
54. (17beta)-3-hydroxyestra-1(10),2,4-trien-17-yl Heptanoate
55. Estra-1,3,5(10)-triene-3,17-diol (17beta)-17-heptanoate
56. Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 17-heptanoate
57. (1s,10r,11s,14s,15s)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-yl Heptanoate
Molecular Weight | 384.6 g/mol |
---|---|
Molecular Formula | C25H36O3 |
XLogP3 | 7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 7 |
Exact Mass | 384.26644501 g/mol |
Monoisotopic Mass | 384.26644501 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 546 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Estrogens
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. (See all compounds classified as Estrogens.)
Market Place
ANALYTICAL
ABOUT THIS PAGE
53
PharmaCompass offers a list of Estradiol Enanthate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Estradiol Enanthate manufacturer or Estradiol Enanthate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Estradiol Enanthate manufacturer or Estradiol Enanthate supplier.
PharmaCompass also assists you with knowing the Estradiol Enanthate API Price utilized in the formulation of products. Estradiol Enanthate API Price is not always fixed or binding as the Estradiol Enanthate Price is obtained through a variety of data sources. The Estradiol Enanthate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3001 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3001, including repackagers and relabelers. The FDA regulates DSSTox_CID_3001 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3001 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3001 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3001 supplier is an individual or a company that provides DSSTox_CID_3001 active pharmaceutical ingredient (API) or DSSTox_CID_3001 finished formulations upon request. The DSSTox_CID_3001 suppliers may include DSSTox_CID_3001 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3001 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_3001 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_3001 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_3001 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_3001 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DSSTox_CID_3001 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_3001 USDMF includes data on DSSTox_CID_3001's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_3001 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DSSTox_CID_3001 suppliers with USDMF on PharmaCompass.
DSSTox_CID_3001 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_3001 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_3001 GMP manufacturer or DSSTox_CID_3001 GMP API supplier for your needs.
A DSSTox_CID_3001 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3001's compliance with DSSTox_CID_3001 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_3001 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3001 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_3001 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3001 EP), DSSTox_CID_3001 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3001 USP).